Chris Nolet's Net Worth
$747 Thousand
Who is Chris Nolet?
Chris Nolet does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., Revance Therapeutics, Inc., Viela Bio, Inc., Jasper Therapeutics, Inc., and POLARITYTE, INC..
SEC CIK
Chris Nolet's CIK is 0001782814
Past Insider Trading and Trends
2022 was Chris Nolet's most active year for acquiring shares with 6 total transactions. Chris Nolet's most active month to acquire stocks was the month of April. 2021 was Chris Nolet's most active year for disposing of shares, totalling 2 transactions. Chris Nolet's most active month to dispose stocks was the month of December. 2021 saw Chris Nolet paying a total of $79,892.64 for 178,007 shares, this is the most they've acquired in one year. In 2023 Chris Nolet cashed out on 39,575 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ArriVent Biopharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revance Therapeutics, Inc. (RVNC) Snapshot price: $6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.10% | 3.53K |
—
|
—
| 28.61K |
May 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +31.87% | 6.06K |
—
|
—
| 25.07K |
May 4
| |||
Form 4
| +26.75% | 4.01K |
—
|
—
| 19.01K |
May 5
| |||
Form 4
| +66.67% | 6K |
—
|
—
| 15K |
May 14
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viela Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $17.645
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 32.5K |
—
|
—
| 32.5K |
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
POLARITYTE, INC. (PTEIQ) Snapshot price: $0.1421
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -71.70% | -36.50K |
—
|
—
| 14.4K |
Jan 12
| |||
Form 4
|
∞
| 50.9K |
—
|
—
| 50.9K |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||